Table 1.
Relationship between the expression levels of circCYP24A1 and clinicopathological features in RCC.
| Characteristics | No. (%) | circCYP24A1 expression | ||
|---|---|---|---|---|
| High (%) | Low (%) | P-value | ||
| Gender | ||||
| Male | 46 (56.1) | 20 (43.5) | 26 (56.5) | 0.557 |
| Female | 36 (43.9) | 18 (50.0) | 18 (50.0) | |
| Age | ||||
| <60 | 35 (42.7) | 14 (40.0) | 21 (60.0) | 0.320 |
| ≥60 | 47 (57.3) | 24 (51.1) | 23 (48.9) | |
| Tumor size | ||||
| <3 cm | 33 (40.2) | 20 (60.6) | 13 (39.4) | 0.034 |
| ≥3 cm | 49 (50.8) | 18 (36.7) | 31 (63.3) | |
| TNM stage | ||||
| I | 72 (87.8) | 37 (51.4) | 35 (48.6) | 0.014 |
| II–IV | 10 (12.2) | 1 (10.0) | 9 (90.0) | |
| Total | 82 | 38 | 44 | |